Scribe Therapeutics Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,918 | $2,233 | $4,898 | $17,125 |
Net Income | -6,477 | -17,347 | -9,903 | -3,425 |
Net Change In Cash | 1,918 | 2,233 | 4,898 | 17,125 |
Free Cash Flow | -5,347 | -7,572 | -7,070 | -14,112 |
Cash | 35,586 | 20,381 | ||
Basic Shares | 17,577 | 17,577 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $51,174 | $27,413 |
Net Income | -21,808 | -47,786 |
Net Change In Cash | 51,174 | 27,413 |
Free Cash Flow | -46,484 | -46,584 |
Cash | 12,796 | 12,602 |
Basic Shares | 17,577 | 17,577 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$3.84 |